Symbiomix Therapeutics Announces Publication of Pivotal Data for Investigational Solosec™ for the Treatment of Bacterial Vaginosis

World News: . []

Symbiomix Therapeutics today announced the publication of positive data from a pivotal clinical trial of single dose Solosec secnidazole oral granules for the treatment of bacterial vaginosis BV 1 Data from the randomi...

More news and information about Symbiomix Therapeutics

Published By:

Business Wire: 14:48 GMT Monday 17th July 2017

Published: .

Search for other references to "symbiomix" on SPi News

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
Sector Publishing Intelligence Ltd.
Ground Floor Offices, Little Keep Gate, Barrack Road, Dorchester, Dorset DT1 1AH
Registered in England and Wales number 0751938.
Privacy Policy | Terms and Conditions | Contact Us

Advertising on SPi News: Information For Advertisers